HOWL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Werewolf Therapeutics Inc (HOWL) is not a good buy for a beginner, long-term investor at this time. The stock shows weak financial performance, no significant positive catalysts, and hedge funds are heavily selling. Additionally, technical indicators and options data do not suggest a strong entry point.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 50.246, and moving averages are converging, showing no clear trend. Key support is at 0.86, with resistance at 0.975. The stock is trading below its pivot level, signaling weakness.
NULL identified. No recent news or significant insider activity.
Hedge funds are aggressively selling, with a 755.50% increase in selling over the last quarter. Financial performance is deteriorating with negative revenue growth, declining EPS, and a significant drop in net income. No recent congress trading data or influential figure activity.
In 2025/Q4, revenue remained at 0 with no growth. Net income dropped by -58.92% YoY to -$8.38M, EPS fell by -65.22% YoY to -0.16, and gross margin declined by -100.00%. The company shows no signs of financial improvement.
No recent analyst ratings or price target changes available.
